B. Riley Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
SAM
GA
AA
OFA
PFS
AIP
ONB
VFM
QCM
B. Riley Wealth Advisors's NVO Position: Q2 2026 in Review
B. Riley Wealth Advisors opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,224 shares worth $204K. The stake represents 0.01% of the portfolio and ranks #765 among its holdings. This is a return to the name: B. Riley Wealth Advisors previously reported a position in NVO as recently as Q4 2025.
B. Riley Wealth Advisors first reported a position in NVO in Q2 2014 and has held it in 22 quarters since. The position peaked at $8.49M in Q2 2024. 240 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- B. Riley Wealth Advisors held 4,224 shares of Novo Nordisk worth $204K as of Q2 2026.
- Novo Nordisk was a new B. Riley Wealth Advisors position in Q2 2026.
- Novo Nordisk made up 0.01% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #765 holding.
- B. Riley Wealth Advisors first reported a position in Novo Nordisk in Q2 2014 and has held it in 22 quarters since.
- B. Riley Wealth Advisors's Novo Nordisk position peaked at $8.49M in Q2 2024.
- 240 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.